We tested serial serum samples for hepatitis C virus RNA from patients undergoing treatment for chronic hepatitis C with interferon-a using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 20 patients with chronic hepatitis who had serum antibody
Reduction of serum ghrelin concentration during interferon-α therapy in patients with chronic hepatitis C
✍ Scribed by Hisayoshi Watanabe; Takafumi Saito; Testuru Karasawa; Shun Kudo; Kuniaki Nakano; Jun-Itsu Ito; Kazuhiko Sugahara; Koji Saito; Hitoshi Togashi; Sumio Kawata
- Book ID
- 108138237
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 185 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1386-6346
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferon‐α (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes
Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus R N A became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 m